Deep learning radiomics of ultrasonography: Identifying the risk of axillary non-sentinel lymph node involvement in primary breast cancer

Xu Guo,Zhenyu Liu,Caixia Sun,Lei Zhang,Ying Wang,Ziyao Li,Jiaxin Shi,Tong Wu,Hao Cui,Jing Zhang,Jie Tian,Jiawei Tian
DOI: https://doi.org/10.1016/j.ebiom.2020.103018
IF: 11.205
2020-10-01
EBioMedicine
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Completion axillary lymph node dissection is overtreatment for patients with sentinel lymph node (SLN) metastasis in whom the metastatic risk of residual non-SLN (NSLN) is low. However, the National Comprehensive Cancer Network panel posits that none of the previous studies has successfully identified such subset patients. Here, we develop a multicentre deep learning radiomics of ultrasonography model (DLRU) to predict the risk of SLN and NSLN metastasis.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>In total, 937 eligible breast cancer patients with ultrasound images were enrolled from two hospitals as the training set (<em>n</em> = 542) and independent test set (<em>n</em> = 395) respectively. Using the images, we developed and validated a prediction model combined with deep learning radiomics and axillary ultrasound to sequentially identify the metastatic risk of SLN and NSLN, thereby, classifying patients to relevant axillary management groups.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Findings</h3><p>In the test set, the DLRU yields the best performance in identifying patients with metastatic disease in SLNs (sensitivity=98.4%, 95% CI 96.6–100) and NSLNs (sensitivity=98.4%, 95% CI 95.6–99.9). The DLRU also accurately stratifies patients without metastasis in SLN or NSLN into the corresponding low-risk (LR)-SLN and high-risk (HR)-SLN&amp;LR-NSLN category with the negative predictive value of 97% (95% CI 94.2–100) and 91.7% (95% CI 88.8–97.9), respectively. Moreover, compared with the current clinical management, DLRU appropriately assigned 51% (39.6%/77.4%) of overtreated patients in the entire study cohort into the LR group, perhaps avoiding overtreatment.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Interpretation</h3><p>The performance of the DLRU indicates that it may offer a simple preoperative tool to promote personalized axillary management of breast cancer.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Funding</h3><p>The National Nature Science Foundation of China; The National Outstanding Youth Science Fund Project of National Natural Science Foundation of China; The Scientific research project of Heilongjiang Health Committee; The Postgraduate Research &amp;Practice Innovation Program of Harbin Medical University.</p>
medicine, research & experimental
What problem does this paper attempt to address?